Boston Scientific’s SCS leads linked to 1,081 serious injuries in FDA alert
The US Food and Drug Administration (FDA) has issued an alert over Boston Scientific’s recall of a lead kit used …
The US Food and Drug Administration (FDA) has issued an alert over Boston Scientific’s recall of a lead kit used …
The US Food and Drug Administration (FDA) has started working with six drug-device manufacturers involved in the production of transdermal …
Cepheid’s haemorrhagic fever panel has become the fourth diagnostic for detecting the Bundibugyo (BVD) Ebola virus strain to receive an …
Globus Medical has secured the CE mark for its Excelsius3D imaging system, clearing the way for commercial sales of the …
US-based HR HealthCare has launched the Liv Pre-lubricated Intermittent Catheter, a device developed to support women managing their bladder health …
Heartvue.ai’s machine learning–powered software for cardiovascular magnetic resonance image (MRI) evaluation and analysis has secured US Food and Drug Administration …
Summer is officially behind us and we're turning our attention to Q4. Here's a sneak peek of what we have …
Intravascular lithotripsy (IVL) is moving into routine interventional cardiology practice, but adoption is still shaped by practical constraints. IVL uses …
Elucid has raised $55m to further develop its artificial intelligence (AI)-based cardiovascular imaging platform and support preparations for the anticipated …
Hamamatsu Photonics has received 510(k) approval from the US Food and Drug Administration (FDA) for its NanoZoomer S20MD and NanoZoomer …
PixCell Medical has entered the Canadian market through a new distribution agreement with Inter Medico, following the granting of a …
Flosonics has won a contract worth up to $70m from the US Department of Health and Human Services’ (HHS) Biomedical …
Huawei’s health ambitions are moving beyond the smartwatch. At the European Society of Cardiology Congress (ESC) in Munich, the Chinese …
Vara has secured a European CE mark for an autonomous, artificial intelligence (AI)-powered breast cancer screening triage tool – marking …
HU Group Holdings’ wholly owned subsidiary Fujirebio has received Class II Medical Device Licences from Health Canada for its Lumipulse …